Most of today's presentation by Scott Cormack at the Stifel Nicolaus conference was inaudible. Maybe they can post a transcript on the website.
I did catch a little news on the parts that were audible (at the beginning and the end):
1. They hope to announce interim results on 427 for the P2 prostate trial and the P1 bladder trial around February.
2. In response to a question, Cormack said they may or may not partner 427. He said they'll have results on the P2 bladder trial for 427 around the time the P3 trials for 011 in prostate end in late 2013, so if the 011 results are good the money they get from Teva could fund further development of 427.
Just listened to the archived recording. The sound isn't as bad as it was on the live webcast. Still a rough patch for about 10 minutes when the Q&A begins but after that it's pretty smooth sailing. (The whole webcast is about 30 minutes.) Not much news other than what I mentioned above but the Q&A format allows Cormack to explain some things in more depth than usual.
I laughed when I saw the footnote "Per sponsor estimates on www.clintrials.gov or inferred from data therefrom"
This is as if he is talking about a company with which he is not very familiar.
This "updatephobia" is getting funny. I heard that when Scott Cormack goes home and when spouse asks "how are you?" he answers "according to http://www.cdc.gov or inferred from data therefrom, I have another 55 years to live. Thanks for asking" :)